Live Breaking News & Updates on Stryker corp

Stay informed with the latest breaking news from Stryker corp on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Stryker corp and stay connected to the pulse of your community

S&P 500 Futures Drop in Premarket Trading; Paramount Global, Paramount Global Lead

With U.S. stock markets set to open in two hours, (PARAA) was up 19.2% in pre-market trading, and (PARA) was up 17.5%. (MANH), (SYK), and (EQR) were all...

Manhattan , New-york , United-states , Manhattan-associates-inc , York-community-bancorp-inc , Stryker-corp , Rockwell-automation-inc , Equity-residential , New-york-community-bancorp , Rockwell-automation , Article-normal

Medical device makers' stocks jump as procedures keep going strong

Shares of Stryker, Boston Scientific and other medical technology companies jumped Wednesday as healthy demand for medical procedures brightened investors'...

Boston , Massachusetts , United-states , Kevin-lobo , Boston-scientific-corp , Stryker-corp , Boston-scientific , Article-normal , Medical-equipment-supplies , Building-construction , Diversified-holding-companies , Healthcare-life-sciences

MI couple gives $100M to Spelman College, largest single gift to a Black college

A billionaire couple is giving $100 million to Atlanta's Spelman College, which the women's school says is the largest-ever single donation to a historically Black college or university.

Michigan , United-states , Minnesota , Western-michigan-university , New-york , Reed-hastings , Ronda-stryker , George-floyd , Helene-gayle , Lovette-russell , Michael-bloomberg , Jeff-bezos

GLP-1 not all loss, sweet side emerges for med tech

Investors bailed on many med-tech companies last year, fearing that the frenzy surrounding GLP-1 agonists would tank companies in the weight-loss, diabetes and orthopedics segments. Their concerns now appear overblown in many instances, with some of the most directly affected businesses reporting a “rising tide” associated with an increased focus on obesity treatment that has lifted their boats rather than sinking them.

Bioworld-medtech , Zimmer-biomet-holdings-inc- , Stryker-corp- , Abbott-laboratories-inc- , Dexcom-inc- , Reshape-lifesciences-inc- , Insulet-corp- , Tandem-diabetes-care-inc- , Allurion-technologies-inc- , Glp-1 , Endocrine-metabolic

Johnson & Johnson puts orthopedics unit under the knife

Johnson & Johnson will excise less profitable lines and markets within its Depuy Synthes orthopedics business over the next two years, management revealed in its quarterly investor call on Oct. 16. Paring its products and related pursuits could cost as much as $800 million by the end of 2025, J&J Chief Financial Officer Joe Wolk said.

Depuy-synthes , Joe-wolk , Johnson , Johnson-amp , Depuys-synthes , Velys , Stryker-corp- , Zimmer-biomet-inc- ,